<DOC>
	<DOCNO>NCT00199680</DOCNO>
	<brief_summary>In cervical cancer prognosis factor size tumour , pelvic para-aortic lymph node involvement . The initial treatment take determined lymph node evaluation . Early stage cervical cancer begin , lymph node involvement , treat either surgery radiotherapy , time . At advanced stage , proximal IB IIB bad prognosis ( tumour large 4 cm pelvic lymph node involvement ) , well cancer distal stage IIB , III IVA , treatment relies radio-chemotherapy , either alone pre-surgery . The pre-therapeutic complete examination cervical cancer include clinical examination pelvic MRI order look pelvic para-aortic lymph node precise volume spread tumour pelvic area . A meta-analysis estimating interest MRI show variable sensitivity specificity detection lymph node metastasis sensitivity vary 24 75 % specificity 84 100 % accord study . As use 18-FDG PET scan detect lymph node involvement , study realize far perform , usually , small number subject heterogeneous population . However , seem examination enables well detection lymph node MRI , especially para-aortic lymph node depend study , sensitivity varies 57 100 % , specificity 92 100 % . We propose prospective , multicentric multidisciplinary study estimation diagnosis method . The main aim estimate interest 18-FDG PET scan detection pelvic para-aortic lymph node metastasis patient cervical cancer , comparison MRI . This study enable include 380 patient within 3 year . An 18-FDG scintigraphy perform treatment together MRI . A comparison sensitivity specificity examination establish correlation histology lymph node dissection make .</brief_summary>
	<brief_title>Interest PET Imagery With 18-FDG Extension Assessment Cervical Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Patient cervical carcinoma : histological proof epidermoid carcinoma adenocarcinoma Stage I IV ( limited pelvic ) ( FIGO Classification ) ( see appendix 3 ) Age â‰¥ 18 year old No contraindication surgery Dated , inform sign consent patient Metastatic cervical cancer extrapelvic metastasis Contraindication MRI : implantation electronic device , metallic ferromagnetic foreign body Serious coexist affection vital prognosis Diabetes uncontrolled classical treatment : glycaemia &gt; 1.4g/l Pregnancy lactation Uncontrolled infection Other cancer within previous 5 year , except skin basal cell carcinoma , situ cervical cancer Patient deficiency prevent completely understanding requirement study , might compromise patient 's consent and/or observance protocol consistent participation study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>PETscan , cervical cancer</keyword>
</DOC>